Atrial fibrillation: diagnosis and management

You can now review and comment on this draft guideline.

The consultation closes on Wednesday 4 November at 5pm.

How to comment

1. Register your organisation or comment as an individual

If you’re commenting for an organisation, your organisation needs to be registered as a stakeholder.

Not eligible? Contact the stakeholder organisation that most closely represents your interests and pass your comments to them.

We can accept comments from individuals. These will be considered, but you won’t get a formal response and they won’t be posted on the NICE website. Wherever possible we encourage you to submit your comments through a registered stakeholder organisation.

2. Read the consultation documents

Documents to comment on:

• Draft guideline - Just the recommendations
• Evidence reviews:
  • Evidence review A: Effectiveness of tests for detection
  • Evidence review B: Accuracy of tests for detection
  • Evidence review C&D: Tools to predict stroke in people with atrial fibrillation
  • Evidence review E&F: Risk stratification tools for predicting bleeding in people with atrial fibrillation
  • Evidence review G1: Anticoagulant therapy for stroke prevention in people with atrial fibrillation
  • Evidence review G2: Anticoagulant therapy: health economics analysis
  • Evidence review H: Discontinuing anticoagulation in people whose atrial fibrillation has resolved
  • Evidence review I: Non-ablative rate control therapies
  • Evidence review J1: Ablation
  • Evidence review J2: Ablation: network meta-analysis
  • Evidence review J3: Ablation: health economics analysis
  • Evidence review K: Antiarrhythmic drugs after ablation
  • Evidence review L: Treatment strategies for atrial fibrillation after cardiothoracic surgery
  • Evidence review M: Statins for preventing atrial fibrillation after cardiothoracic surgery
• Acknowledgements
• Algorithm
• Method
• Economic model (see below)

If you want to review the economic model, please see 5. Economic models below and fill in the confidentiality form.

Other information about the consultation

• Equality impact assessment
• Committee membership list and DOI register
• Developing NICE guidelines: how to get involved

3. Add your comments

• You must use this comments form.
• You must declare any links with, or funding from, the tobacco industry

If you share similar views with another organisation, send a joint response.

Make sure you consider:

• The areas that will have the biggest impact on practice and be challenging to implement
• How to help users overcome challenges

Developing NICE guidelines: how to get involved suggests some other areas to comment on.

4. Email the form to us

Email: AFmanagement@nice.org.uk

Deadline: Wednesday  4 November at 5pm.

5. Economic model

The developer has produced an economic model to support the guideline on Atrial Fibrillation: Management. To receive an executable version of this model, please submit a request to AFmanagement@nice.org.uk with a signed copy of the confidentiality acknowledgement and undertaking form.

We will then send you a link to an executable version of the economic model by email. The deadline for returning your comments is the same as for the guideline consultation: Wednesday 4 November at 5pm.